MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcard.2020.06.021

Медицинская библиотека · International journal of cardiology · 2020

The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study.

Zhang Dongfeng, Song Xiantao, Raposeiras-Roubín Sergio, Abu-Assi Emad, Henriques Jose Paulo Simao, D'Ascenzo Fabrizio, Saucedo Jorge, González-Juanatey José Ramón, Wilton Stephen B, Kikkert Wouter J, Nuñez-Gil Iván, Ariza-Sole Albert, Alexopoulos Dimitrios, Liebetrau Christoph, Kawaji Tetsuma, Moretti Claudio, Huczek Zenon, Nie Shaoping, Fujii Toshiharu, Correia Luis, Kawashiri Masa-Aki, Southern Danielle, Kalpak Oliver

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Acute myocardial infarction (AMI) recurrence is still high despite great progress in secondary prevention. Patients with recurrent AMI suffer worse prognosis compared to those with first AMI. The objective was to evaluate the effect of optimal medical therapy (OMT) on these patients with recurrent AMI.

METHODS AND

RESULTS

Sub-analysis was performed including 13,343 patients with AMI from the international multicenter Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome (BleeMACS) registry. OMT was defined as the combination of aspirin, any P2Y12 inhibitor, statin, angiotensin converting enzyme inhibitor/angiotensin receptor blocker, and beta-blocker. Among 1285 patients with prior AMI, 56.8% received OMT prescription. Patients receiving OMT suffered from less congestive heart failure, peripheral artery disease, malignancy, and bleeding history. Kaplan-Meier survival estimates revealed that OMT was strongly related to decreased in all-cause death (4.2% vs. 10.1%, p < .001) and the composite endpoint of death/re-AMI (11.1% vs. 16.9%, p = .005) at 1-year follow-up. OMT was the independent protect factor of primary endpoint even after adjusting for multiple possible confounders (HR, 0.46; 95% CI, 0.27-0.78; p = .004). However, no significant difference was observed regarding re-AMI between OMT and non-OMT groups. OMT also reduced all-cause death in patients with recurrent AMI after propensity score matching.

CONCLUSIONS

The prescription of OMT was seriously insufficient in patients with recurrent AMI, especially high-risk patients, even though OMT was associated with improved prognosis. Further improvements in pharmacological therapy are needed to reduce subsequent recurrent events.

Для цитирования: Zhang Dongfeng, Song Xiantao, Raposeiras-Roubín Sergio, Abu-Assi Emad, Henriques Jose Paulo Simao, D'Ascenzo Fabrizio, Saucedo Jorge, González-Juanatey José Ramón, Wilton Stephen B, Kikkert Wouter J, Nuñez-Gil Iván, Ariza-Sole Albert, Alexopoulos Dimitrios, Liebetrau Christoph, Kawaji Tetsuma, Moretti Claudio, Huczek Zenon, Nie Shaoping, Fujii Toshiharu, Correia Luis, Kawashiri Masa-Aki, Southern Danielle, Kalpak Oliver. The impact of optimal medical therapy on patients with recurrent acute myocardial infarction: Subanalysis from the BleeMACS study.. International journal of cardiology. 2020. DOI: 10.1016/j.ijcard.2020.06.021.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.